Suzuki T - Search Results

1

N⁺-C-H···O Hydrogen bonds in protein-ligand complexes.

Itoh Y, Nakashima Y, Tsukamoto S, Kurohara T, Suzuki M, Sakae Y, Oda M, Okamoto Y, Suzuki T. Itoh Y, et al. Among authors: suzuki m, suzuki t. Sci Rep. 2019 Jan 25;9(1):767. doi: 10.1038/s41598-018-36987-9. Sci Rep. 2019. PMID: 30683882 Free PMC article.

2

Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate.

Suzuki T, Kouketsu A, Itoh Y, Hisakawa S, Maeda S, Yoshida M, Nakagawa H, Miyata N. Suzuki T, et al. J Med Chem. 2006 Aug 10;49(16):4809-12. doi: 10.1021/jm060554y. J Med Chem. 2006. PMID: 16884291

3

Identification of a potent and stable antiproliferative agent by the prodrug formation of a thiolate histone deacetylase inhibitor.

Suzuki T, Hisakawa S, Itoh Y, Maruyama S, Kurotaki M, Nakagawa H, Miyata N. Suzuki T, et al. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1558-61. doi: 10.1016/j.bmcl.2006.12.117. Epub 2007 Jan 13. Bioorg Med Chem Lett. 2007. PMID: 17257837

4

Design, synthesis, and biological activity of folate receptor-targeted prodrugs of thiolate histone deacetylase inhibitors.

Suzuki T, Hisakawa S, Itoh Y, Suzuki N, Takahashi K, Kawahata M, Yamaguchi K, Nakagawa H, Miyata N. Suzuki T, et al. Among authors: suzuki n. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4208-12. doi: 10.1016/j.bmcl.2007.05.040. Epub 2007 May 17. Bioorg Med Chem Lett. 2007. PMID: 17532630

5

Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors.

Itoh Y, Suzuki T, Kouketsu A, Suzuki N, Maeda S, Yoshida M, Nakagawa H, Miyata N. Itoh Y, et al. Among authors: suzuki n, suzuki t. J Med Chem. 2007 Nov 1;50(22):5425-38. doi: 10.1021/jm7009217. Epub 2007 Oct 11. J Med Chem. 2007. PMID: 17929798

6

Isoform-selective histone deacetylase inhibitors.

Itoh Y, Suzuki T, Miyata N. Itoh Y, et al. Among authors: suzuki t. Curr Pharm Des. 2008;14(6):529-44. doi: 10.2174/138161208783885335. Curr Pharm Des. 2008. PMID: 18336298 Review.

7

Identification of G protein-coupled receptor 120-selective agonists derived from PPARgamma agonists.

Suzuki T, Igari S, Hirasawa A, Hata M, Ishiguro M, Fujieda H, Itoh Y, Hirano T, Nakagawa H, Ogura M, Makishima M, Tsujimoto G, Miyata N. Suzuki T, et al. J Med Chem. 2008 Dec 11;51(23):7640-4. doi: 10.1021/jm800970b. J Med Chem. 2008. PMID: 19007110

8

Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors.

Hamada S, Kim TD, Suzuki T, Itoh Y, Tsumoto H, Nakagawa H, Janknecht R, Miyata N. Hamada S, et al. Among authors: suzuki t. Bioorg Med Chem Lett. 2009 May 15;19(10):2852-5. doi: 10.1016/j.bmcl.2009.03.098. Epub 2009 Mar 26. Bioorg Med Chem Lett. 2009. PMID: 19359167

9

Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors.

Hamada S, Suzuki T, Mino K, Koseki K, Oehme F, Flamme I, Ozasa H, Itoh Y, Ogasawara D, Komaarashi H, Kato A, Tsumoto H, Nakagawa H, Hasegawa M, Sasaki R, Mizukami T, Miyata N. Hamada S, et al. Among authors: suzuki t. J Med Chem. 2010 Aug 12;53(15):5629-38. doi: 10.1021/jm1003655. J Med Chem. 2010. PMID: 20684604

10

Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.

Suzuki T, Khan MN, Sawada H, Imai E, Itoh Y, Yamatsuta K, Tokuda N, Takeuchi J, Seko T, Nakagawa H, Miyata N. Suzuki T, et al. J Med Chem. 2012 Jun 28;55(12):5760-73. doi: 10.1021/jm3002108. Epub 2012 Jun 12. J Med Chem. 2012. PMID: 22642300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21,929 results

Search Page